Search

CBD - search results

If you're not happy with the results, please do another search

0 348

Cannabis Sativa, Inc. Launches Hi Honey at Hempcon 420 Freedom Fest, Ibudtender Subsidiary is Official Voting Platform

Pre-production packaging of the hi honey product will be available for sale this weekend at HempCon for consumer feedback. HempCon is America’s largest cannabis industry, health, life style, culture & music expo held in April 21st through April 23rd in San Francisco. If you plan to attend HempCon, stop by the Southern Star Healing booth to preview the hi honey and White Rabbit products.

Ibudtender is the official voting platform of 420 Freedom Fest, keeping the competition fair and equal. A mix of industry/patient judges and testing data determines the best products and strains in the California market. Every entry is tested for potency, pesticides, microbiology, residual solvents and terpenes to ensure product safety.

View photos

Forward-Looking Statements:

This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact Information:

Investor Relations
Mesquite, NV 89027
702-345-4074

http://www.cannabissativainc.com

0 400

Endexx Begins Shipment of Third Eye Chai CBD-Infused Gourmet Tea Beverages

Endexx’s first product launch Third Eye Chai™, a masala chai tea, was a result of its license and distribution deal with The Mad Hatter Coffee & Tea Co. The collaboration offers a major opportunity to bring specific hemp and CBD-infused natural blends to the global health and whole foods markets, a major step for the cross-over markets valued at over $3 billion.

Todd Davis, CEO of Endexx, stated, “Our CBD-infused Chai, is primarily a wellness product that contains only the finest tea and herb ingredients and provides our customers with an enhanced tea experience. Although there is still a lot of education to be done on the health benefits of CBD, it has been proven to alleviate inflammation, muscle spasms, anxiety, epileptic seizures, and pain. Our licensing and partnership agreement with The Mad Hatter Coffee & Tea Co., will initially allow us to distribute our tea in the US, following with global distribution. This first product launch enables Endexx to generate licensing agreements with several large family owned conglomerates and distributors that have expressed strong interest in licensing our products, providing for additional revenue opportunities.”

About Endexx
Endexx provides innovative inventory management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 — the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “End of Sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense™ is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.m3hub.com.

Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3130797

0 1432

CBD oil, a hemp derivative, could be the next treatment for your chronic, acute seasonal allergies. For some time now, self-medicating people have been aware that CBD oil works as a powerful treatment for asthma and COPD by suppressing the symptoms that lead to an attack. Now there is a paper in the journal Pulmonary Pharmacology and Therapeutics to back them up: CBD treatments have proven to stop the decrease of airway flow and make breathing easier. Furthermore, when an allergen was introduced into the subjects, CBD oil helped control the production and behavior of mast cells; the white blood cells that freak out when an allergen enters your body and produce histamines, the part of our immune system that provide the classic effects of allergies: sneezing, rashes, itching, coughing, all the fun stuff.

Other benefits of cannabinoids for allergy sufferers: control inflammation, open the sinus passageways, relieve nasal pressure, manage pain, and induce calmness and sleep. Histamine production is also kicked up when we are super-active or stressed out, but it is mellow when we are mellow, and pretty much stops when we sleep. And remember, CBD is the compound in cannabis that doesn’t get you high, meaning there’s no reason it can’t serve as a regular treatment for these issues. However, if you have the day off, do consider the “entourage effect.” When THC and CBD work together, they both do a better, more complete job. CBD oils or edibles with as little as 3 percent THC will induce this effect without getting you too high.

If you are feeling the effects of spring already starting to kick in, consider blending some locally grown whole-plant CBD-rich oil with a hyper-local honey at a dosage level that allows you to take half a teaspoon a day. Antimicrobial and antibacterial, honey has been used as a medicine for thousands of years. Hyper-local honey is created by bees in your city, maybe even your neighborhood, and it contains the pollens you are breathing in daily and possibly reacting to. Taking small doses of honey containing these local pollens can, for some, act as an inoculation against those allergens, reducing or eliminating your reactions to them.

0 2234

HempLife Today Expands Free Trial Pack of CannazALL CBD GelCaps to the General Public

Free trial pack to all

This free trial pack will consist of six (6) 25mg CannazALL™ CBD GelCaps derived from Hemp and packed with up to 200% more important plant Terpenes for added benefit, along with instructions and additional information about the company and its products.

CEO James Ballas said, “We believe in our company and we believe in our products, and the more people who experience our products the better. In fact, I’d like to see us giveaway as many thousands of free GelCaps packs as possible. It’s an exciting way to get more of our product into the hands of more people and create new lifelong customers as well, and it speaks volumes about the quality of our Company.”

Everyone is eligible to receive a free trial size of six (6) CannazALL™ CBD GelCaps by simply clicking on the link or visiting www.HLTFreeTrials.com

The Company reserves this offer to one free trial pack per person and two per household, but otherwise encourages everyone to share this giveaway with as many others as possible.

This giveaway is available until midnight Eastern on Friday, April 14, and all free trial packs requested will be shipped by April 30th 2017.

About HempLife Today™

Hemp Life Today™ was created by a group of highly motivated, skilled and health minded people. Who have learned that Hemp, and Hemp related products, can be a great source of increased health, vitality, and overall well being in our lives. We also believe that high grade CBD (Cannabidiol), could very well be the miracle supplement the world has been waiting for as more and more people discover the health benefits of this remarkable extract. HempLife Today™ offers its quality CBD products @ www.HempLifeToday.com

About Ubiquitech

Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday™.

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Honey, and e-liquid, all offered @ www.HempLifeToday.com

This press release contains forward-looking statements. Words such as “expects”, “intends”, “believes”, and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company’s filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward- looking statements in order to reflect events or circumstances that may arise after the date of this release.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3128147

0 2289

HempLife Today Announces Free Trial Pack of CannazALL CBD GelCaps to All Existing Shareholders, Their Families and Friends

Free trial pack to all existing shareholders

This free trial pack will consist of six (6) 25mg CannazALL™ CBD GelCaps derived from Hemp and packed with up to 200% more important plant Terpenes for added benefit, along with instructions and additional information about the company and its products.

CEO James Ballas said, “In everything that I do as CEO of HempLife Today, I keep the shareholders in mind. This free trial pack giveaway of our Cannazall CBD GelCaps are the same ones I use and it’s just another way of showing our appreciation for the continued support of the shareholders of ( OTC PINK : UBQU ). CannazALL™ is a growing CBD brand with over 25,000 customers throughout the US and I know our shareholders will absolutely love our GelCaps once they try them!”

To get your free trial size of six (6) CannazALL™ CBD GelCaps, existing shareholders, and their families and friends, simply logon to www.HempLifeInvestors.com

The Company will verify all existing shareholders with the Company’s NOBO list, as of the close of business on Wednesday, April 05, 2017.This giveaway is available until midnight Eastern on Thursday, April 13th, 2017, and all free trial packs requested will be shipped by April 20th, 2017.

About HempLife Today™

HempLife Today™ was created by a group of highly motivated, skilled and health minded people who have learned that Hemp, and Hemp related products, can be a great source of increased health, vitality, and overall wellbeing in our lives. We also believe that high grade CBD (Cannabidiol), could very well be the miracle supplement the world has been waiting for as more and more people discover the health benefits of this remarkable extract. HempLife Today™ offers its quality CBD products @ www.HempLifeToday.com

About Ubiquitech

Ubiquitech Software Corp., through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLife Today™.

HempLife Today™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include: its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Honey, and e-liquid, all offered @ www.HempLifeToday.com

This press release contains forward-looking statements. Words such as “expects”, “intends”, “believes”, and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company’s filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

0 1157
cbd stocks

Two marijuana reform bills were recently signed by Virginia Governor Terry McAuliffe (D), ending the state’s automatic six-month driver’s license suspension for first time possession offenders and allowing the production of CBD oil. This may look like a couple drops in a raging storm of national decriminalization, but NORML Executive Director, Erik Altieri, said it’s a huge accomplishment.

Altieri stated, “The two measures signed into law in Virginia this week may seem like baby steps, but they are the culmination of years of dedicated advocacy and legislative outreach. While neither of these bills will end the arrest of around 18,000 Virginians a year for marijuana possession or create an ideal, accessible medical marijuana program, they represent important progress in terms of growing legislative support for marijuana law reforms.”

When Senate Bill 1091 (which ends Virginia’s automatic ID suspension penalty) goes into effect at the beginning of July, it will be left at the court’s discretion whether or not to impose this condition as a term of probation, and convicts will still be subject to other conditions under Virginia law, including substance abuse screening, drug testing and community service. Minors are still subject to automatic license suspension under the new law.

For many years Virginia has all but topped the list of places you didn’t want to be caught with marijuana. In recent years Virginia has seen quite the increase in enforcement. According to data collected by the Drug Policy Alliance, marijuana possession arrests increased from approximately 13,000 in 2003 to almost 23,000 in 2014, an increase that was especially pronounced in majority Black neighborhoods.

Now that McAuliffe’s put pen to paper, the state should begin to see continued progress in this area, which has already seen some improvement since 2014. This past December, Newport News reported that the number of people arrested or charged with marijuana offenses had fallen by 14% statewide over a two-year stretch. This is step in the right direction, but putting real decriminalization laws on the books is the real answer to ending the waste and social destruction of cannabis prohibition. Keeping strict laws on the books but applying lenient, quasi-enforcement standards creates the potential for serious trouble.

Under “selective enforcement,” those who are most affected and targeted by law enforcement now; communities of colors would continue to carry that burden. In the three years from 2011 to 2013, marijuana possession arrests increased by 1,987 in Virginia; black people accounted for 82% of that increase. The Marijuana Policy Project referred to SB 1027 as an “extremely narrow law.” It will allow those suffering from intractable epilepsy to access CBD oils produced in state by Department of Health-approved pharmaceutical companies.

0 1642

HempLife Today set to capitalize on recent retired NFL players and Celebrity endorsements of Cannabidiol (CBD), and the awareness generated

Over the last 12 months many notable NFL athletes and celebrities have spoken about CBD (Cannabidiol), and how it gave them relief from pain and ailments both common and more serious, and this publicity is helping to fuel the awareness of CBD in the US and around the world. Below is just a sample of these statements and endorsements;

“I was open for anything at that point to try. And once I tried it and was consistent on CBD, that’s when I realized, ‘Wow, this stuff works” Jake Plummer/ Former Denver Broncos starting quarterback / CBSnews.com

“I’ve had friends, guys I played alongside, whose mood changed from night to day. I know others who’ve replaced hellacious amounts of painkillers with CBD” Jake Plummer/ Former Denver Broncos starting quarterback / Denver Post

“For me, I feel like if you don’t want to get high, this is a product specifically just to get rid of discomfort” Whoopi Goldberg
“It’ll [CBD Oil] make your life a better place” – Nate Diaz Lightweight and Welterweight UFC fighter.

In addition to Nate Diaz, Lightweight and Welterweight UFC fighter Donald “Cowboy” Cerrone talks about the benefits of CBD and how he uses it for training and pain relief on The Joe Rogan Experience episode number 699, one of the largest Podcasts in the world today.

Other notable celebrities who have publicly endorsed the use of CBD are; Morgan Freeman, Montel Willliams, Tommy Chong, and Mellissa Etheridge.

Even Dr. Sanjay Gupta of CNN has been endorsing the benefits of CBD on his many episodes of “Weed” since 2013, and this first public endorsement of CBD by a well known doctor has continued to resonate.

HempLife Today™ sees a direct correlation of these endorsements and an increase in Internet traffic and searches for CBD and related links. With its solid footprint on the Internet and the ever growing awareness of CBD and the CannazALL™ CBD product line, the Company believes that as more notable people publicly talk about their CBD use this trend will continue and it will result in increased sales for the company.

“We are starting to see that CBD awareness is going above the 5% mark in the general public” Said Luke Dreyer, Operations manager “and this means that the tide is rising and CBD awareness is increasing. This is what boosts our monthly and quarterly sales apart from our other major marketing initiatives. This is free publicity for a product that people want and you can’t get better than that.”

“We definitely see the increase in awareness benefiting our company” adds James Ballas, CEO “and this is why we built our company the way that we did, to constantly take advantage of the massive free publicity about this product that grows daily. So let’s add it up…We have developed the finest Hemp derived CBD products that we can, in a legal alternative to medical marijuana that we can deliver to all 50 states. Traffic to our site is growing daily and all of our marketing efforts are off the scale in profitability, plus, we get a ton of free publicity by doctors, celebrities, athletes, and more, not to mention the incredible word of mouth by our customers. Not bad, and we will continue to grow the Company in this manner.”

About Ubiquitech (HempLife Today™)

Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday™

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It’s popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Honey, and e-liquid, all offered @ www.HempLifeToday.com

0 1722

The combination of CBD and THCV (tetrahydrocannabivarin) looks to have significant therapeutic potential in the treatment of Type 2 diabetes. Research concerning THCV and Type 2 diabetes has been making scientific news for at least three years. THCV is what chemists call the propyl variant of THC. While THCV is psychoactive, it’s a shorter, more intense high than THC. THC is a few hours at the amusement park; THCV is an hour on the roller coaster.

Appetite suppression is another side effect of THCV. The science concerning THCV and weight loss is not well-developed. No one knows how long the effect lasts and how much weight loss can be expected. Even with that caveat, the possibilities are intriguing. The weight-loss industry is worth $60 billion a year, the same as the cannabis industry. What happens when those two industries intersect? Venture capital apoplexy. World domination.

It turns out that there aren’t any high THCV/CBD strains out there. Even THCV by itself is hard to find in any significant concentration. The strains Jack the Ripper and Durban Poison have approximately 2% THCV. Doug’s Varin has closer to 7% THCV, but it has a reputation as a scrawny plant. The strain Willie Nelson has some THCV, but none of the people in my circles know anything about it.

There is a micro-grow (10 plants) in Sonoma County with a strain code named Elizabeth Taylor with 6.7% THCV and 12% THC. It’s a robust plant with the highest terpene (essential oils that give cannabis strains their unique aromatics) profile measured around here.

The big-market potential from secondary cannabinoids, thin science and the lack of THCV/CBD rich genetics is (IMO) the perfect opportunity for any forward-thinking entrepreneur. Whether it’s THCV or something else (CBDV?), our cannabis future, both economic and cultural, will be shaped, not by what we know, but by what we will be able to learn.

0 1062
CBD

Before American Revolution, the domestic production of hemp in the United States began. The government strongly encouraged that hemp crops be grown to continue the manufacturing of clothing, rope, and sails and, in 1619, the Virginia Assembly passed legislation that mandated all farmers to grow hemp.

After the Civil War, hemp production began to hinder as other materials began to increase in popularity. Yet, cannabis, a mixture of dried flowers and leaves from the hemp plant, continued to be used in nearly every medicine on the shelf at most pharmacies. Even after World War II’s “Hemp for Victory” campaign, during which farmers were encouraged to produce hemp for marine cordage, parachutes, and other military provisions, the process of the cannabis restriction continued.

It wasn’t until 1970 that the Comprehensive Drug Abuse Prevention and Control Act characterized cannabis differently than narcotics, eliminating harsh minimum federal sentencing mandates. The rush of societal knowledge that marijuana could be used for medical purposes for patients with HIV, cancer, and a many other conditions followed directly behind President George H.W. Bush’s 1989 War on Drugs, during which marijuana didn’t fare so well.

In Indiana’s congress, there are currently 10 house and Senate proposals on medical marijuana and cannabidiol (CBD), a substance within the hemp plant that offers medicinal qualities without the psychedelic effect. Some of the proposals have already been voted down. Others are still moving forward. One such bill is House Bill 1148, authored by Representative William Friend (R-Dist. 23). Friend’s measure proposes immunity for parents who are offered a treatment plan that includes CBD, as well as immunity for the doctors recommending that course of treatment.

Friend stated, “Over the last few years, we have, in the ag committee, sponsored bills for industrial hemp. Not only for introduction as another crop that Hoosier farmers could produce, but also for its medicinal values. We’ve heard some compelling testimony for the last three to four years from desperate parents who have children with juvenile epilepsy. These children may have multiple seizures per hour. They may have to wear helmets. They have used all the pharmaceutical remedies such as sedatives, barbiturates, and other medications and have been unsuccessful.”

Friend added that it has been found that CBD oil may be more than 80% effective in reducing or controlling seizures. He said, “I am not proposing that we legalize marijuana or medical marijuana or even CBD oil. I just want to make it possible for these parents not to be prosecuted.” Friend’s proposal just had its third reading and has moved on to be heard in the Senate. Republican Representative Don Lehe is one of 38 co-authors named on Friend’s bill. While he has no interest in supporting legislation for medical marijuana, he does see the benefit for certain patients on cannabidiol. Lehe stated, “Everything involved in the cannabis family is designated as illegal. Until they (marijuana and CBD oil) are separated, the oil is considered illegal. CBD oil has virtually no THC.”

0 1123

Lexaria Introduces TurboCBD(TM) Brand of High Absorption Full Spectrum Hemp Oil Capsules

Lexaria Bioscience Corp (LXRP)(CSE:LXX) (LXX.CN) (CNSX:LXX) (the “Company” or “Lexaria”) announces the introduction of the TurboCBD™ brand of technologically enhanced, high absorption full spectrum hemp oil capsules. Lexaria’s TurboCBD™ capsules are specially formulated with the finest American Ginseng and Ginkgo Biloba for support of enhanced focus and memory, and reduced stress and fatigue.

TurboCBD™ capsules utilize Lexaria’s patented absorption technology and are triple tested for purity. They are made without the use of organic solvents and leave no hemp oil aftertaste. They are vegan, gluten-free, sugar-free, nut-free and made in the USA. They will soon be offered for sale through California medical cannabis dispensaries and other select locations as the perfect complement to any cannabis regimen.

Lexaria’s TurboCBD™ capsules are designed to work with the physiology of the human gastrointestinal system where minute quantities of long chain fatty acids like sunflower oil, combined in each serving of TurboCBD™ capsules, are thoroughly and quickly absorbed into the circulatory system for maximum effectiveness. In vitro and human focus study testing has shown increases in CBD absorption using Lexaria’s technology by as much as 5-10 times more than conventional preparations. Those studies also demonstrated rapid onset of action in as little as 15 minutes.

Lexaria intends to showcase its TurboCBD™ capsules at the upcoming 2017 World Medical Marijuana Business Conference & Expo in Pittsburgh on April 21 and 22, which is expected to attract over 8,000 cannabis professionals including 1,200 physicians interested in the sector.

Lexaria is further researching other capsule formulations utilizing its patented absorption technology, each of which would be uniquely formulated to address specific market demands. Testing with Lexaria’s technology has shown equally good improvements in enhancing absorption and rapidity of action when working with THC as shown for CBD, and Lexaria continues to develop and seek opportunities to lever its technology for THC product applications through licensees in the USA, Canada and internationally.

About Lexaria

Lexaria Bioscience Corp is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also improving taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that Lexaria’s TurboCBD™ capsules, specially formulated with the finest American Ginseng and Ginkgo Biloba, will provide any support of enhanced focus and memory or reduced stress and fatigue. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria Energy Foods and ViPova™ products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements